Literature DB >> 10352903

Cytopathologic evaluation of lung carcinomas presenting as brain metastasis.

C V Reyes1, K S Thompson, J D Jensen.   

Abstract

Brain metastasis is an uncommon initial presentation of lung carcinoma. One arm of this analysis is a retrospective review of 137 cases of surgically diagnosed solitary brain metastasis, which were eventually found to be of lung origin, encountered at Hines VA Hospital during the period 1958 to 1996. The second arm is composed of fine-needle aspiration biopsy specimens of primary lung tumor in 23 patients with an initial clinical diagnosis of brain metastasis and without the benefit of surgery, seen from 1981 through 1996. Our results in both analyses indicate that pulmonary adenocarcinoma is the predominant primary tumor that initially manifests as a brain metastasis, approaching 76% (107 and 17 cases, respectively), followed by small-cell carcinoma at 20% (24 and five cases, respectively) and large-cell undifferentiated carcinoma and squamous-cell carcinoma at 2% each. The predominance of adenocarcinoma as a source of brain metastasis in lung cancer patients probably reflects its rising incidence overall of late. Collateral findings also suggest that surgical resection of a solitary and small brain metastasis as well as of a discrete lung primary, whenever feasible, as the most effective procedure to improve survival and quality of life of patients.

Entities:  

Mesh:

Year:  1999        PMID: 10352903     DOI: 10.1002/(sici)1097-0339(199906)20:6<325::aid-dc1>3.0.co;2-n

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  Pontine metastases as a cause of dysphagia in lung carcinoma.

Authors:  Alejandro Vara-Castrodeza; Juan Carlos Torrego-García; Javier Luis Puertas-Alvarez; Marcelino Mendo-González
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

2.  Posterior fossa metastasis in lung cancer patients with vertigo.

Authors:  Shunji Hiyashi; Po-Wen Cheng; Yi-Ho Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-01       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.